The Viking study results add to the growing excitement around the biotech company and its potential in the budding weight loss market.

Boeing’s next CEO must handle the company’s safety crisis and quality problems as well as growing competition from Airbus and Chinese manufacturers.

Canada Goose said Tuesday that it will cut about 17% of its corporate workforce as consumers continue to pull back on discretionary spending. 

Krispy Kreme will more than double its distribution to reach McDonald’s restaurants nationwide.

Pacaso lists shares of vacation homes, generally an eighth but sometimes larger shares, and then facilitates the purchase, including financing if necessary.

The EPA’s percentage targets for EV adoption are not mandates but expectations for how automakers can meet its new regulations.

The move is hardly shocking, given the acrimonious nature of the battle. In recent weeks, Disney has stepped up its attacks on Trian and Peltz.

Amgen is testing a monthly injection that works differently and appears to help patients maintain their weight loss even after they stop taking it.

Some patients are willing to pay more for GLP-1 weight loss drugs like Wegovy than others — and it’s strongly correlated to their annual income.

Boeing CEO Dave Calhoun will step down at the end of 2024 in part of a broad management shakeup for the embattled aerospace giant.